FDA cleared platform Scanwell Health holds the distinction of having FDA 510(k) clearance for an over‑the‑counter diagnostic smartphone application, indicating a compliant, consumer‑ready platform that can be leveraged to pitch regulated at‑home testing solutions to healthcare providers and retailers seeking compliant tech.

Strategic partnerships Historic collaborations with BD for at‑home COVID‑19 testing apps suggest strong potential for new partnerships with major diagnostics or medical device firms seeking smartphone‑enabled testing capabilities and scalable app integrations.

Low headcount agility With a lean team of 2–10 employees, there are significant opportunities to position Scanwell as a flexible, outsourcing friendly partner for white‑label software development, integration services, and medical device data capture initiatives.

Multi‑disease expansion Current momentum around expanding from infectious diseases to broader at‑home diagnostics (malaria, COVID‑19, influenza) signals a sales angle to healthcare systems and payers looking to consolidate at‑home testing across multiple conditions on a single platform.

Tech stack readiness Proven tech footprint including mobile apps, Python, Django, C++, and iOS, combined with machine learning and computer vision focus, positions Scanwell as a suitable collaborator or acquisition target for health tech integrators aiming to accelerate digital health product lines.